Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCR-Lite plus Lenalidomide in Previously Untreated CLL
NCT01723839Phase 2Completed
- Sponsor
- Hackensack Meridian Health
- Start
- Feb 2012
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in chronic lymphocytic leukemia (CLL), sponsored by Hackensack Meridian Health. Started Feb 2012; status: completed.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01723839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01723839.